The content is available as a PDF (347.0 KB).
letter . 2020 Oct 26:ciaa1626. doi: 10.1093/cid/ciaa1626
COVID-19 and preventative medicine for HIV infected children
Lorato Anderson
1,✉, Miguela Caniza
2
Lorato Anderson, MD
1
Pediatric HIV Fellow at St. Jude’s Children’s Research Hospital,
Memphis, TN
Find articles by Lorato Anderson
Miguela Caniza, MD, MPH
2
Director, Global Infectious Diseases Program, St. Jude Children’s Research
Hospital, Memphis, TN
Find articles by Miguela Caniza
1
Pediatric HIV Fellow at St. Jude’s Children’s Research Hospital,
Memphis, TN
2
Director, Global Infectious Diseases Program, St. Jude Children’s Research
Hospital, Memphis, TN
✉
Corresponding author: Lorato Anderson, MD, Pediatric HIV Fellow at St. Jude’s Children’s Research Hospital, Email: Lorato.Anderson@stjude.org, Phone: 609-456-3626
Received 2020 Sep 8.
© The Author(s) 2020. Published by Oxford University Press for the
Infectious Diseases Society of America. All rights reserved. For permissions, e-mail:
journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7665378 PMID: 33103186
See the reply "Reply to Anderson and Caniza" in volume 73 on page e2835.